Loading clinical trials...
Loading clinical trials...
Neoadjuvant Combination of Atezolizumab/Bevacizumab Versus Neoadjuvant Radiation Therapy Prior to Hepatectomy in Hepatocellular Carcinoma with Portal Vein Tumour Thrombus (ADVANCE HCC) Hoffmann La Roche Protocol Number: ML42525
Conditions
Interventions
Neoadjuvant
Locations
7
Canada
Tom Baker Cancer Centre
Calgary, Alberta, Canada
Cross Cancer Institute
Edmonton, Alberta, Canada
Juravinski Cancer Centre
Hamilton, Ontario, Canada
Ottawa Regional Cancer Centre
Ottawa, Ontario, Canada
Princess Margaret Cancer Centre
Toronto, Ontario, Canada
8. Centre the recherche du Centre hospitalier de l'Université de Montréal - CHUM
Montreal, Quebec, Canada
Start Date
October 18, 2022
Primary Completion Date
February 26, 2025
Completion Date
February 26, 2025
Last Updated
March 11, 2025
NCT07485114
NCT06066138
NCT06811116
NCT06345508
NCT04380545
NCT07291076
Lead Sponsor
Ontario Clinical Oncology Group (OCOG)
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions